Gene · 4261
Papers3,496
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
1,601 to 1,620 of 3,496
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The predictors and patterns of the early recurrence of pancreatic ductal adenocarcinoma after pancreatectomy: the influence of pre- and post- operative adjuvant therapy. | BMC Surg | 2019 | 31796066 | PubTator, text mining | PubMed |
| Liver-Mediated Adaptive Immune Tolerance. | Front Immunol | 2019 | 31787967 | PubTator, text mining | PubMed |
| Restriction factors in human retrovirus infections and the unprecedented case of CIITA as link of intrinsic and adaptive immunity against HTLV-1. | Retrovirology | 2019 | 31783769 | PubTator, text mining | PubMed |
| The NLRP3 p.A441V Mutation in NLRP3-AID Pathogenesis: Functional Consequences, Phenotype-Genotype Correlations and Evidence for a Recurrent Mutational Event. | ACR Open Rheumatol | 2019 | 31777803 | PubTator, text mining | PubMed |
| Antigen presentation and tumor immunogenicity in cancer immunotherapy response prediction. | Elife | 2019 | 31767055 | PubTator, text mining | PubMed |
| Genistein Modulates Signaling Pathways and Targets Several Epigenetic Markers in HeLa Cells. | Genes (Basel) | 2019 | 31766427 | PubTator, text mining | PubMed |
| Immunopeptidomics of colorectal cancer organoids reveals a sparse HLA class I neoantigen landscape and no increase in neoantigens with interferon or MEK-inhibitor treatment. | J Immunother Cancer | 2019 | 31735170 | PubTator, text mining | PubMed |
| A pilot study of peripheral blood DNA methylation models as predictors of knee osteoarthritis radiographic progression: data from the Osteoarthritis Initiative (OAI). | Sci Rep | 2019 | 31727952 | PubTator, text mining | PubMed |
| Identification and Analyses of Extra-Cranial and Cranial Rhabdoid Tumor Molecular Subgroups Reveal Tumors with Cytotoxic T Cell Infiltration. | Cell Rep | 2019 | 31708418 | PubTator, text mining | PubMed |
| Prognostic and clinicopathological significance of PD-1/PD-L1 expression in the tumor microenvironment and neoplastic cells for lymphoma. | Int Immunopharmacol | 2019 | 31704289 | PubTator, text mining | PubMed |
| The genetic architecture of helminth-specific immune responses in a wild population of Soay sheep (Ovis aries). | PLoS Genet | 2019 | 31697674 | PubTator, text mining | PubMed |
| Immune and Inflammatory Cells of the Tumor Microenvironment Represent Novel Therapeutic Targets in Classical Hodgkin Lymphoma. | Int J Mol Sci | 2019 | 31694167 | PubTator, text mining | PubMed |
| Direct prediction of regulatory elements from partial data without imputation. | PLoS Comput Biol | 2019 | 31682602 | PubTator, text mining | PubMed |
| Immunometabolism of Phagocytes During Mycobacterium tuberculosis Infection. | Front Mol Biosci | 2019 | 31681793 | PubTator, text mining | PubMed |
| NLRX1 Is a Multifaceted and Enigmatic Regulator of Immune System Function. | Front Immunol | 2019 | 31681307 | PubTator, text mining | PubMed |
| Advances in asthma and allergic disease genetics: Is bigger always better? | J Allergy Clin Immunol | 2019 | 31677964 | PubTator, text mining | PubMed |
| The impact of proinflammatory cytokines on the β-cell regulatory landscape provides insights into the genetics of type 1 diabetes. | Nat Genet | 2019 | 31676868 | PubTator, text mining | PubMed |
| STING-Mediated IFI16 Degradation Negatively Controls Type I Interferon Production. | Cell Rep | 2019 | 31665637 | PubTator, text mining | PubMed |
| Immunogenicity of prostate cancer is augmented by BET bromodomain inhibition. | J Immunother Cancer | 2019 | 31653272 | PubTator, text mining | PubMed |
| Refining diffuse large B-cell lymphoma subgroups using integrated analysis of molecular profiles. | EBioMedicine | 2019 | 31648986 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/4261/papers?page=81